10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will report first quarter 2026 financial results for the period ended March 31, 2026 on May 7, 2026 after market close. A public conference call and live webcast will begin at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments and outlook.

The company said the news release with financial results will be posted on its investor website prior to the call, and the webcast will be archived for at least 45 days.

News Market Reaction – TXG

-0.43%

-0.43% Session close to close

In the Apr 16 session, TXG declined 0.43%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for 10x Genomics’ Q1 2026 results on May 7, 2026, with a confer...

Analysis

This announcement sets the timetable for 10x Genomics’ Q1 2026 results on May 7, 2026, with a conference call at 1:30 p.m. PT / 4:30 p.m. ET and a webcast replay for at least 45 days. Investors may look back to the recent Q4/FY2025 release and 2026 revenue guidance of $600M–$625M as context, focusing on how Q1 performance tracks against that outlook.

Key Figures

Quarter end date: March 31, 2026 Earnings release date: May 7, 2026 Conference call time PT: 1:30 p.m. +2 more

5 metrics

Quarter end date March 31, 2026 First quarter 2026 reporting period

Earnings release date May 7, 2026 Scheduled Q1 2026 financial results release after market close

Conference call time PT 1:30 p.m. Public conference call start, Pacific Time

Conference call time ET 4:30 p.m. Public conference call start, Eastern Time

Webcast replay period 45 days Archived replay availability after event

Previous Earnings date Reports

1 past event · Latest: Jan 22 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 22	Earnings date notice	Neutral	-3.5%	Announced timing and webcast details for Q4 and full-year 2025 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The only prior earnings date headline over the past 6 months saw a modest negative move of -3.49% on the announcement.

Recent Company History

Recent news for 10x Genomics includes AI and spatial biology partnerships, large-scale atlases, and Q4/FY2025 results with 2026 revenue guidance of $600M–$625M. The stock has reacted positively to several innovation-focused updates and to the last earnings release, but a prior earnings date notice on Jan 22, 2026 coincided with a -3.49% move. Today’s announcement again sets expectations ahead of a scheduled quarterly report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLEASANTON, Calif., April 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended March 31, 2026 after market close on Thursday, May 7, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content:https://www.prnewswire.com/news-releases/10x-genomics-to-report-first-quarter-2026-financial-results-on-may-7-2026-302743619.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) report Q1 2026 results and what time is the earnings call?

10x Genomics will report Q1 2026 results on May 7, 2026 after market close. According to the company, the public conference call and live webcast begin at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and outlook.

How can investors access the 10x Genomics (TXG) May 7, 2026 webcast and where is it hosted?

Investors can access the live webcast via the company's investor website at investors.10xgenomics.com. According to the company, the webcast will be streamed on the Investors section and available for live listening and viewing during the call.

Will the 10x Genomics (TXG) Q1 2026 webcast be available after the May 7 event and for how long?

Yes, the webcast will be archived and available for replay. According to the company, the archived webcast will remain accessible for at least 45 days after the event for on-demand viewing.

What topics will 10x Genomics (TXG) cover on the May 7, 2026 earnings call?

The company will discuss its Q1 2026 financial results, business developments, and outlook. According to 10x Genomics, management will review results and provide commentary for analysts and investors during the call and webcast.

Will the Q1 2026 press release be posted before the 10x Genomics (TXG) earnings call on May 7?

Yes, the company said the news release with financial results will be posted on its investor website prior to the conference call. This allows investors to review figures before management's discussion on the call.

How can analysts and investors participate in the 10x Genomics (TXG) May 7, 2026 conference call?

Analysts and investors can join the public conference call and webcast via the investor website link. According to the company, the event is open to the public and will include a live Q&A component for participants.